More on APUS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (11/20/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Apimeds (NY:APUS)
Delayed: 1.41 +0.06 (4.44%)
Prev. Close $1.35  
Open$1.35 
52 Wk High$ 
52 Wk Low$ 
Day High$1.50 
Day Low$1.35 
P/E N/A  
EPS$ 
Volume57,798 


May 26, 2026 04:14 PM Form 10-Q Apimeds Pharmaceuticals For: Mar 31
May 15, 2026 04:09 PM Form NT 10-Q Apimeds Pharmaceuticals For: Mar 31
May 7, 2026 09:12 AM Form SCHEDULE 13D/A Apimeds Pharmaceuticals Filed by: Inscobee Inc.
May 5, 2026 02:15 PM Apimeds Pharma shares soar on Inscobee settlement
May 5, 2026 02:08 PM Apimeds halted on volatility
May 5, 2026 02:07 PM Apimeds settles with Inscobee, clears path for merger and $100M financing
May 5, 2026 02:07 PM Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
May 5, 2026 12:30 PM Form 8-K Apimeds Pharmaceuticals For: May 05
May 4, 2026 06:57 AM Form 10-K Apimeds Pharmaceuticals For: Dec 31
May 4, 2026 06:15 AM Form 8-K Apimeds Pharmaceuticals For: Apr 24
View All Articles

Entities mentioned with APUS

View All Entities